Covid-19: Regeneron’s antibody combination cuts deaths in seronegative patients, trial finds
Regeneron’s antibody combination treatment cut deaths in seronegative patients—meaning those who had not mounted their own antibody response to covid-19—by one fifth, the Recovery trial has…
